The role of CD58 and CD38 in evaluation of minimal residual disease in childhood B-acute lymphoblastic leukemia - Egyptian Knowledge Bank - troweb

163290

The role of CD58 and CD38 in evaluation of minimal residual disease in childhood B-acute lymphoblastic leukemia

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia

Article

Role of CD58 in minimal residual disease detection of ALL patients at South Egypt Cancer Institute

Article

ROLE OF CD200 IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

Article

Prognostic Role of Tetraspanin CD81 in Patients with Acute Myeloid Leukemia

Article

Prognostic Impact of CD200 Expression in Pediatric Acute Lymphoblastic Leukaemia

Article

SIGNIFICANCE OF ABERRANT CD 82 EXPRESSION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

Article

The Role of CD133 and CD73 in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Article

Clinical Significance of CD200 and CD56 in Patients with Acute Lymphoblastic Leukemia

Article

CD86: A Novel Prognostic Marker in Acute Lymphoblastic Leukemia Patients

Article

Assessment of CD34 using immunohistochemistry in bone marrow biopsies of acute myeloid leukemia patients.